MPXV蛋白质支架和基于抗原的宏分子多抗原显示下一代疫苗,提供协调的幽默和细胞反应
Ankit Gupta1, Priyasi Mittal1, Puneet Srivastva1
1Centre for Virus Research, Therapeutics and Vaccines, Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana, 121001, India.
International journal of biological macromolecules
|February 5, 2026
概括
一种新的双价架聚蛋白候选疫苗被开发用于orthopoxviruses. 这种疫苗引起强烈的幽默和细胞免疫反应,提供对致命的病毒感染的保护.
科学领域:
- 病毒学 病毒学
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
背景情况:
- 下一代针对像病毒 (MPXV) 这样新兴的骨病毒的疫苗需要提供来自细胞内成熟病毒 (IMV) 和细胞外包裹病毒 (EEV) 形式的抗原的平台.
- 传统的多抗原联合免疫策略在有效地呈现多种抗原方面面临挑战.
- 存在需要定义的宏分子平台,能够引起协调的幽默和细胞免疫反应对orthopoxviruses.
研究的目的:
- 为结构引导抗原显示设计MPXV蛋白质支架,使多个抗原的呈现成为可能.
- 为了生成一种基于双价蛋白子单元的候选疫苗 (BSP),针对幽默和细胞/细胞毒性T细胞反应.
- 为了评估BSP的免疫性和防护效果,对正病毒的挑战.
主要方法:
- 设计了一个MPXV蛋白质支架,以容纳多个抗原以进行结构引导显示.
- 产生了一种表达M1和A35抗原的双价支架聚蛋白 (BSP) 候选疫苗.
- 用BSP免疫的小鼠和评估的幽默性 (抗体标位) 和细胞性 (CD8+和CD4+T细胞反应) 免疫.
- 挑战免疫小鼠使用致命的神经向性疫苗病毒 (VACV) 菌株来评估保护.
主要成果:
- 溶性BSP引起高位抗MPXV抗原特异性幽默反应,并平衡了小鼠的Th1型CD8+和CD4+细胞反应.
- 支架蛋白本身充当了抗原,诱导了抗MPXV幽默,细胞毒性T细胞和抗VACV中和反应.
- 辅助的BSP提供了对致命的呼吸道VACV挑战的完整保护,从大脑中清除了病毒.
结论:
- 工程化蛋白质支架提供了一个灵活的,结构导向的平台,用于开发多价值的orthopoxvirus疫苗.
- 双价支架多蛋白质候选疫苗表明,它有可能引起针对骨架病毒的综合免疫反应.
- 这种平台允许快速的抗原替代,促进未来的疫苗开发,以应对新出现的骨髓炎病毒威胁.
关键词:
这是一个相当的二元期权.细胞毒性T细胞反应MPXVMPXV MPXVVMPXVMPXVMPXVMPXVMPXVMPXVMPMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPXVMPX成熟和包裹的病毒.脚手架 脚手架是一个脚手架.疫苗病毒是疫苗病毒.相关概念视频
Humoral Immune Responses
84.0K
Overview
84.0K
Vaccinations
51.7K
Overview
51.7K
Antigen Presenting Cells
3.3K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
3.3K
Diversity of Antigen Receptors
1.6K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.6K
Antigen Processing Pathways
2.3K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
2.3K
Antigens Involved in Adaptive Immunity
1.5K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.5K


